BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4614967)

  • 21. Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidus.
    Radó JP; Marosi J; Szende L; Takó J
    Endokrinologie; 1973 Dec; 62(3):297-309. PubMed ID: 4790811
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperuricemia, a concomitant of congenital vasopressin-resistant diabetes insipidus in the adult.
    Gorden P; Robertson GL; Seegmiller JE
    N Engl J Med; 1971 May; 284(19):1057-60. PubMed ID: 5553195
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of diabetes insipidus with carbamazepine.
    Wales JK
    Lancet; 1975 Nov; 2(7942):948-51. PubMed ID: 53432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of antidiuretic preparations used in treating diabetes insipidus patients].
    Kolomoĭskaia MB; Latypova GA
    Vrach Delo; 1984 Apr; (4):76-9. PubMed ID: 6204458
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral antidiabetic agents on diuresis in diabetes insipidus of the vasopressin-responsive and the nephrogenous types.
    László FA; Czakó L
    Acta Med Acad Sci Hung; 1971; 28(2):196-204. PubMed ID: 5148333
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetes insipidus. Clinico-pharmalogical correlations and their therapeutic results with various substances].
    Holgado Silva C; De la Vega Vázquez JM; Bolaños Díaz A; Fajardo Gálvez J; Aznar Reig A
    Rev Clin Esp; 1978 Feb; 148(4):381-4. PubMed ID: 653059
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JR; Szende L; Marosi J
    Metabolism; 1974 Nov; 23(11):1057-63. PubMed ID: 4214480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 34. Lypressin (Diapid) and other drugs for diabetes insipidus.
    Med Lett Drugs Ther; 1972 Dec; 14(26):98-9. PubMed ID: 4648574
    [No Abstract]   [Full Text] [Related]  

  • 35. [Letter: A synthetic analog of vasopressin (DDAVP). Value in the treatment of pitressin-sensitive diabetes insipidus].
    Toursel F; Fontaine G
    Nouv Presse Med; 1975 Jan; 4(3):190. PubMed ID: 1093122
    [No Abstract]   [Full Text] [Related]  

  • 36. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM
    Obstet Gynecol; 1986 Aug; 68(2):288-9. PubMed ID: 3737046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Familial primary vasopressin resistant diabetes insipidus sensitive to biguanide].
    Villamor J; Hita J; Barreiro P; Ortiz Vázquez J; Vãzquez JJ
    Rev Clin Esp; 1971 Apr; 121(1):51-62. PubMed ID: 5563103
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Familial diabetes insipidus of central origin (author's transl)].
    Bruguier A; Poisson D; Lestradet H; Labrune B
    Nouv Presse Med; 1981 Mar; 10(11):897-9. PubMed ID: 7208293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiuretic responses to hypertonic saline infusion, water deprivation, and a synthetic analogue of vasopressin in patients with hereditary, hypothalamic diabetes insipidus.
    Andersson KE; Arner B; Fürst E; Hedner P
    Acta Med Scand; 1974; 195(1-2):17-23. PubMed ID: 4817085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.